Institutional Giants Bet Big on Hims & Hers Stock

A wave of aggressive buying by major financial institutions has swept over Hims & Hers Health, Inc. Recent regulatory filings reveal a stunning accumulation of shares by some of Wall Street’s most prominent players during the third quarter of 2025, signaling a powerful vote of confidence despite recent stock price volatility.

Leading the charge was JPMorgan Chase, which bolstered its portfolio by approximately 15.04 million shares—a staggering increase of 549%. This move represents an investment estimated at $853 million. The banking giant was not alone in its bullish stance. Tidal Investments amplified its stake by an extraordinary 1,779%, while asset manager T. Rowe Price reported a 444% increase in its holdings. Farallon Capital also significantly Read more...